MC

Mahesh Chiguru

Active Director Director DIN 10557012
DIN 10557012 First appointment Mar 2024 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value •••• Premium profile

About Mahesh Chiguru

Data last updated:

Mahesh Chiguru is a Director at Stemgrow Pharmaceuticals Private Limited (since 2024). The company operates in Chemicals. Stemgrow Pharmaceuticals Private Limited reported revenue of ₹51.9 Lakh (FY 2024).

DIN 10557012
Primary Designation Director
Industry Chemicals
First Appointment 21 Mar 2024
Oldest Company Age 4 yrs
Largest company Stemgrow Pharmaceuticals Private Limited · ₹51.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Mar 20242022₹51.9 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Stemgrow Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mahesh Chiguru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahesh Chiguru

Mahesh Chiguru currently holds 1 directorship: Stemgrow Pharmaceuticals Private Limited (Director, since 21 Mar 2024, revenue ₹51.9 Lakh (FY 2024)).

Mahesh Chiguru was first appointed on 21 Mar 2024 as Director at Stemgrow Pharmaceuticals Private Limited.

The current boards of Mahesh Chiguru's companies include Gopalreddy Busireddy (Stemgrow Pharmaceuticals Private Limited), Ramesh Gogulakonda (Stemgrow Pharmaceuticals Private Limited), Shivakumar Pasula (Stemgrow Pharmaceuticals Private Limited), Srikanth Sankati (Stemgrow Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available